Screening-Based Translation of Public Research Encounters Painful Problems
- 9 February 2015
- journal article
- editorial
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 6 (3) , 229-234
Abstract
Whether identified through high throughput screening or in silico screening, and whether target-based or phenotypic, sets of hits will contain chemical con artists. Such pan-assay interference compounds (PAINS) and other subversive compounds continue to pollute the scientific literature. There are several angles of attack to aid identification of such nonprogressable molecules. One of these rules above all, and this is a demonstration of genuine structure–activity relationships. Recognition of this, which will require a greater effort in medicinal chemistry, will be of general benefit.Keywords
This publication has 32 references indexed in Scilit:
- Rational Design of Small Molecule Inhibitors Targeting the Ras GEF, SOS1Chemistry & Biology, 2014
- Chemistry: Chemical con artists foil drug discoveryNature, 2014
- Small-molecule Bax agonists for cancer therapyNature Communications, 2014
- Identification of a New RXRα Antagonist Targeting the Coregulator-Binding SiteACS Medicinal Chemistry Letters, 2014
- Rational design of small molecules targeting the C2 domain of coagulation factor VIIIBlood, 2014
- PAINS: Relevance to Tool Compound Discovery and Fragment-Based ScreeningAustralian Journal of Chemistry, 2013
- Small-molecule activation of the TRAIL receptor DR5 in human cancer cellsNature Chemical Biology, 2012
- Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery, 2011
- Observations on Screening-Based Research and Some Concerning Trends in the LiteratureFuture Medicinal Chemistry, 2010
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in BioassaysJournal of Medicinal Chemistry, 2010